The Kidney Disease Symptom Score (KDSS) has temporal stability for patients with non-dialysis-dependent chronic kidney ...
Combination therapy with a nonsteroidal mineralocorticoid receptor antagonist and an SGLT2 inhibitor reduced albuminuria more ...
Zacks Investment Research on MSN
4 drug, biotech stocks rising more than 50% in 2025 with room to grow
The drug and biotech sector witnessed a see-saw performance in 2025. After a weak show for most of the year, the sector picked up in the past couple of months. This can be attributed to improved ...
By the time she was 21, her kidney function had fallen so low that she needed a transplant to stay well. She has said that ...
CKD complicates cancer treatment, reducing adjuvant chemotherapy use and increasing mortality risk, necessitating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback